| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |